MoneyWorks4Me

The revenue declined to Rs. 5631.80 millions for the quarter ended June 2023 as compared to Rs. 5650.10 millions during the corresponding quarter last year.A comparatively good net profit growth of 32.44% to Rs. 462.10 millions was reported for the quarter ended June 2023 compared to Rs. 348.90 millions of previous same quarter.Operating profit for the quarter ended June 2023 rose to 799.20 millions as compared to 611.70 millions of corresponding quarter ended June 2022.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202306 202206 % Var 202306 202206 % Var 202303 202203 % Var
Sales 5631.80 5650.10 -0.32 5631.80 5650.10 -0.32 22171.10 21840.20 1.52
Other Income 70.60 51.50 37.09 70.60 51.50 37.09 255.70 320.40 -20.19
PBIDT 799.20 611.70 30.65 799.20 611.70 30.65 2520.90 2883.20 -12.57
Interest 39.50 33.80 16.86 39.50 33.80 16.86 164.70 82.90 98.67
PBDT 759.70 577.90 31.46 759.70 577.90 31.46 2356.20 2661.00 -11.45
Depreciation 144.40 109.80 31.51 144.40 109.80 31.51 461.30 432.60 6.63
PBT 615.30 468.10 31.45 615.30 468.10 31.45 1894.90 2228.40 -14.97
TAX 153.20 119.20 28.52 153.20 119.20 28.52 495.10 571.80 -13.41
Deferred Tax 7.20 -2.40 -400.00 7.20 -2.40 -400.00 32.50 1.70 1811.76
PAT 462.10 348.90 32.44 462.10 348.90 32.44 1399.80 1656.60 -15.50
Equity 587.10 587.10 0.00 587.10 587.10 0.00 587.10 587.10 0.00
PBIDTM(%) 14.19 10.83 31.08 14.19 10.83 31.08 11.37 13.20 -13.87
Peers
Company Name CMP
Sun Pharma. Inds. 1864.00
Dr. Reddys Labs. 1140.80
Cipla 1380.00
Lupin 2075.00
Zydus Lifesciences 1118.00
View more..